| Title: | Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies |
| Journal: | Nature Communications |
| Published: | 31 Jul 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32737316/ |
| DOI: | https://doi.org/10.1038/s41467-020-17668-6 |
| URL: | https://www.nature.com/articles/s41467-020-17668-6.pdf |
Publication 5800
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Integrating results from genome-wide association studies (GWASs) and gene expression studies through transcriptome-wide association study (TWAS) has the potential to shed light on the causal molecular mechanisms underlying disease etiology. Here, we present a probabilistic Mendelian randomization (MR) method, PMR-Egger, for TWAS applications. PMR-Egger relies on a MR likelihood framework that unifies many existing TWAS and MR methods, accommodates multiple correlated instruments, tests the causal effect of gene on trait in the presence of horizontal pleiotropy, and is scalable to hundreds of thousands of individuals. In simulations, PMR-Egger provides calibrated type I error control for causal effect testing in the presence of horizontal pleiotropic effects, is reasonably robust under various types of model misspecifications, is more powerful than existing TWAS/MR approaches, and can directly test for horizontal pleiotropy. We illustrate the benefits of PMR-Egger in applications to 39 diseases and complex traits obtained from three GWASs including the UK Biobank.8 Authors
- Zhongshang Yuan
- Huanhuan Zhu
- Ping Zeng
- Sheng Yang
- Shiquan Sun
- Can Yang
- Jin Liu
- Xiang Zhou
Enabling scientific discoveries that improve human health